CRISPR Therapeutics
CRSP
$53.73
Share price
-3.45%
Change (1 day)
8.70%
Change (1 year)
CRISPR Therapeutics (CRSP) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.34 B
According to CRISPR Therapeutics's latest financial reports the company's total liabilities are $0.34 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
CRISPR Therapeutics - Total liabilities on balance sheet (from 2015 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.34 B | -5.66% |
| 2022-12-31 | $0.36 B | 4.3% |
| 2021-12-31 | $0.35 B | 115.24% |
| 2020-12-31 | $0.16 B | 28.59% |
| 2019-12-31 | $0.12 B | 31.51% |
| 2018-12-31 | $96.82 M | 15.93% |
| 2017-12-31 | $83.51 M | -25.51% |
| 2016-12-31 | $0.11 B | -40.54% |
| 2015-12-31 | $0.18 B | 2117.94% |
| 2014-12-31 | $8.5 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -91.95% | 🇺🇸 USA |